nigericin has been researched along with Hemolysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abay, SM; Basilico, N; Corbett, Y; D'Alessandro, S; Dahiya, N; Dechering, KJ; Gismondo, MR; Grande, R; Habluetzel, A; Ilboudo, DP; Koolen, KM; Misiano, P; Parapini, S; Sauerwein, RW; Taramelli, D | 1 |
1 other study(ies) available for nigericin and Hemolysis
| Article | Year |
|---|---|
Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.
Topics: Antimalarials; Cell Line; Erythrocytes; Hemolysis; Humans; Inhibitory Concentration 50; Ionophores; Molecular Structure; Monensin; Nigericin; Plasmodium berghei; Plasmodium falciparum; Pyrans | 2015 |